November 2019 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- How — And Why — John Oyler Built BeiGene
- From Medtech CEO To Impact Investor — Not Your Typical Retirement Plan
Capitol Perspectives
From Principles and Policy to Execution
Companies To Watch
Industry Research
Inside The Industry
- How To Avoid Data-Integrity Woes In Pharma
- Crossing Over From Supplier To Sponsor
- 7 Elements Of A Successful Biotech Funding Plan
- How Biopharma Leaders Can Ward Off A Perfect Storm: Part 1
- Collecting Competitive Intelligence At Conferences
- Taking It All The Way To Phase 3 Clinical Trials
- Program Strives For More Females On Pharma Boards
Leadership Lessons
Ask The Board
- What Advice Do You Have For Preventing Fraud Schemes In Large Phase 3 Studies?
- What Advice Do You Have For Executives Considering Ex-Pat Opportunities In South American Countries?
- What Advice Do You Have For An Executive Weighing An Exit From A Company For Which They Are A Leader And A Board Member?
This website uses cookies to ensure you get the best experience on our website. Learn more